IFB 25019 - Naloxone

The New York State Office of Addiction Services and Supports (NYS OASAS) announces the release of IFB 25019 - Naloxone. The IFB can be found here: https://oasas.ny.gov/procurement and is anticipated to be posted by COB Friday, 03/06/2026. *Amendment posted on 4/6/2026. Bid Submissions are due 5/1/2026 by 4:00PM EST. Through this Invitation for Bids (“IFB”), the New York State Office of Addiction Services and Supports (NYS OASAS) is seeking competitive bids from (a) eligible organization(s) to provide Food and Drug Administration (FDA) approved intranasal naloxone product, 4 mg per 0.1 mL solution, to NYS OASAS-Approved Providers and related organizations through an online ordering and tracking portal maintained by the bidder. It is the intent of NYS OASAS to make one (1) award from this procurement. Any resulting award will allow for the purchase of Naloxone on an as needed basis, with no guarantee of any purchases, and will be issued as a Purchase Authorization (PA). NYS OASAS anticipates that the initial PA will be for up to $8.0M, however NYS OASAS reserves the right to increase the PA amount if additional Naloxone is needed contingent on all required approvals. Questions are due 3/20/2026 by 4:00PM EST. Business enterprises awarded an identical or substantially similar procurement contract within the past five years: Emergent Devices Inc. P.O. Box 830402 Philadelphia, PA 19182